Glycan masking in vaccine design: targets, immunogens and applications

HIGHLIGHTS

• who: Cristina E. Martina and colleagues from the GlaxoSmithKline, Italy National Tsing Hua University, Taiwan have published the paper: Glycan masking in vaccine design: Targets, immunogens and applications, in the Journal: (JOURNAL)
• what: Sub-types A, B and C account for more than 70% of the global prevalence for HIV worldwide and represent the major focus in the development of therapeutics. In the work of Tai et_al, the DIII domain of the protein E is used as recombinant immunogen candidate, and glycosylation is used to mask the protein side previously in contact with the other . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.